Dismissal Of Investor Claims In Bristol-Myers Securities Suit Affirmed On Appeal
NEW YORK — A federal district court did not err in dismissing shareholder claims in a securities class action lawsuit against drug maker Bristol-Myers Squibb Co. and certain of its current...To view the full article, register now.
Already a subscriber? Click here to view full article